Advertisement
News
Subscribe to MDT Magazine News

Life sciences firms explore ways to help developing nations

August 18, 2010 8:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Is it possible to solve a developing-world pandemic or other similar disease that afflicts the poor and still get rich? One might have to choose between one or the other, say experts, but there may be some options.

TOPICS:

TOPEX Sells Skin Cancer Business Operations to SENSUS Healthcare

August 18, 2010 8:33 am | by Bio-Medicine.Org | Comments

DANBURY, Conn., Aug. 18 /- TOPEX, Inc. announces the sale of its skin cancer business operations to SENSUS Healthcare, LLC for its low energy SRT 100 superficial radiotherapy treatment system. Since TOPEX received FDA approval during 2007, many systems have been operating worldwide at...

TOPICS:

Martek to Announce Third Quarter 2010 Results

August 18, 2010 8:33 am | by Bio-Medicine.Org | Comments

COLUMBIA, Md., Aug. 18 /- Martek Biosciences Corporation (Nasdaq: MATK ) announced today that it intends to release the results of its third quarter of fiscal 2010 on Wednesday, September 1, 2010, at approximately 4:00 p.m. Eastern Time (ET).  At 4:45 p.m. ET Martek will conduct a...

TOPICS:
Advertisement

CardioGenics Featured on Canada's Business News Network

August 18, 2010 8:33 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, Aug. 18 /- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH ), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, took part in an interview on...

TOPICS:

AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality

August 18, 2010 8:32 am | by Bio-Medicine.Org | Comments

NORTH WALES, Pa., Aug. 18 /- AirPal ®, a leading innovator and supplier of lateral air transfer and positioning technology, has announced the expansion of its line of air-activated transfer pads to incorporate multi-purpose patient positioning functionality. "This announcement marks...

TOPICS:

Nominations Open for 2011 Pezcoller Foundation-AACR International Award for Cancer Research

August 18, 2010 8:32 am | by AACR | Comments

PHILADELPHIA - The American Association for Cancer Research is currently accepting nominations for the prestigious Pezcoller Foundation-AACR International Award for Cancer Research.

TOPICS:

Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in...

August 18, 2010 4:36 am | by Bio-Medicine.Org | Comments

FREMONT, Calif., Aug. 18 /- Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor...

TOPICS:

Cardiac Dimensions® Announces Presentation of 12-Month Follow-up Data of TITAN™ Trial at European Society of Cardiology Meeting

August 18, 2010 4:36 am | by Bio-Medicine.Org | Comments

KIRKLAND, Wash., Aug. 18 /- Cardiac Dimensions, an early stage company focused on the development of minimally invasive devices for the treatment of mitral valve disease and congestive heart failure, announced today that the 12-month follow-up results from the TITAN™ trial of the...

TOPICS:
Advertisement

Research could change course of treatment for cancer that spreads to bones

August 18, 2010 4:35 am | by EurekAlert | Comments

(Southern Methodist University) New research holds promise for people whose cancer has spread to their bones. A common treatment for such patients is radiosurgery ? even though little is known about its impact on bone strength, says Edmond Richer at Southern Methodist University, Dallas....

TOPICS:

Out-of-the-ordinary life science ideas offer potential business success

August 17, 2010 10:32 pm | by Mass High Tech: The Journal of New England Technology | Comments

Turning a “cool idea” into the “next big thing” takes perserverence, an unwavering commitment to a vision, and usually, in the life sciences, a boatload of cash. Local entrepreneurs say the challenge lies in convincing funders (or customers) of the value proposition of the product.

TOPICS:

Think of the global good

August 17, 2010 10:31 pm | by Mass High Tech: The Journal of New England Technology | Comments

In this issue we set out to address a core question: How do different types of life sciences companies make money? Yet, there's another question that we also felt it was important to address: Can a company work for the public good even when there is little or no hope of turning a profit?

TOPICS:

VCs discuss potential life science investment pitfalls

August 17, 2010 9:33 pm | by Mass High Tech: The Journal of New England Technology | Comments

Two Boston VCs known for not being shy of risk, SV Life Sciences' James Garvey and PureTech Ventures' Daphne Zohar, told Mass High Tech where they're applying a higher level of scrutiny before investing and what life science categories they're avoiding like the plague.

TOPICS:

Regenerative medicine gets on a profitable roll

August 17, 2010 9:32 pm | by Mass High Tech: The Journal of New England Technology | Comments

After getting off to a false start in the 1990s, the field of regenerative medicine has been reborn over the past decade. Now, several New England companies are showing that regenerative medicine - generally defined as therapy that uses living cells to repair the body - is more than just...

TOPICS:

Cardica signs contract deal with Intuitive

August 17, 2010 2:45 pm | by The Associated Press | Comments

Surgical systems maker Cardica Inc. said Tuesday it entered a licensing deal worth $12 million upfront with Intuitive Surgical Inc.Under the deal, Intuitive will get a worldwide, exclusive license to Cardica's intellectual property, which relates to tissue cutting, stapling and clip appliers,...

TOPICS:

Cardica 4Q loss narrows on smaller sales force

August 17, 2010 2:45 pm | by The Associated Press | Comments

Surgical systems maker Cardica Inc. said Tuesday its fiscal fourth quarter loss narrowed on lower costs following cuts to its sales force.The company lost $3.1 million, or 13 cents per share, compared with a loss of $3.5 million, or 22 cents per share, during the same period a year prior....

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading